Revenue Recognition

9 Months Ended

Sep. 30, 2021

Revenue From Contract With Customer [Abstract]

Revenue Recognition

14.     Revenue Recognition

The following table provides information about disaggregated revenue by product and services:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Product sales and rentals, net	$	849	$	1,465	$	2,734	$	6,331
Processing and storage fees, net		1,343		1,399		4,204		4,213
License related income		8,430		491		9,541		491
Net revenue	$	10,622	$	3,355	$	16,479	$	11,035

The following table provides changes in deferred revenue from contract liabilities:

	2021			2020
Balance at January 1	$	12,449		$	3,833
Deferral of revenue*		3,528			13,734
Recognition of unearned revenue**		(12,161	)		(3,898	)
Balance at September 30	$	3,816		$	13,669

*2020 includes $9,505 received in advance of performing services under a license agreement (see Note 3).  The remainder of the 2020 and all of the 2021 deferral of revenue resulted from payments received in advance of performance under the biobanking services storage contracts that are recognized as revenue under the contract as performance is completed.

** During the third quarter of 2021, the Company terminated the license agreement with Sanuwave due to an uncured material breach (See Note 15). As a result, the Company recognized the remaining deferred revenue of $6,754 that was to be recognized on a straight-line basis over the non-cancelable term of the license agreement.